Physician profile
Christopher Desutter
NPI 1104473883
$3,892.69
in general payments reported to CMS, 2019-2025
13 companies · $14.98 in 2025
The $14.98 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,430 · 2020: $259 · 2021: $912 · 2022: $910 · 2023: $309 · 2024: $57.78 · 2025: $14.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $381.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,668.34 | 2019-2025 | Infinity, Augment Injectable, Infinity Adaptis |
| Arthrex, INC. | $1,059.32 | 2019 | |
| Smith+Nephew, INC. | $250.36 | 2021-2023 | Evos, Maverick, Trigen Intertan |
| Bioventus LLC | $149.76 | 2020-2023 | Exogen Ultrasound Bone Healing System |
| Anika Therapeutics, INC. | $137.39 | 2022 | |
| Goode Surgical INC | $129.11 | 2019 | |
| Acell, INC. | $121.33 | 2019 | |
| Steelhead Surgical INC | $120.87 | 2022 | |
| Wright Medical Technology, INC. | $108.67 | 2020 | |
| Avanos Medical | $73.05 | 2021 | |
| Ossio INC | $32.13 | 2022 | |
| Arthrosurface Incorporated | $21.97 | 2020 | |
| Depuy Synthes Sales INC. | $20.39 | 2023 | Fibergraft Aeridyan Matrix, Motoband, Fibulink |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Desutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.